1-11 of 11
Yan Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health Information Needs of Patients with Hematological Diseases: What Exactly Do They Want?– a Cross-Sectional Survey

Taoyun Liang, Yingli Wang, Yan Yu, Shurong Liu, Ling Mao
Journal: Blood
Blood (2024) 144 (Supplement 1): 7955.
https://doi.org/10.1182/blood-2024-207368
Published: 2024
Journal Articles

VA Combined with Mbucy Conditioning Regimen Followed By Allo-HSCT Can Improve Survival of High-Risk AML Patients: A Prospective, Single-Center, Single-Arm Clinical Trial

Wei Cui, Xiaoqian Chen, Qingya Cui, Zheng Li, Sifan Chen, Mengyun Li, Xuekai Li, Juan Chen, Yan Yu, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3493.
https://doi.org/10.1182/blood-2024-207083
Published: 2024
Journal Articles

Safety and Efficacy of VA Combined with Modified BuCy Conditioning Regimen Followed By Allo-HSCT for High-Risk or Refractory/Relapsed Acute Lymphoblastic Leukemia : A Prospective, Single-Center, Single-Arm Clinical Trial

Xiaoqian Chen, Wei Cui, Qingya Cui, Zheng Li, Sifan Chen, Mengyun Li, Xuekai Li, Juan Chen, Yan Yu, Xin Zhang, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 270.
https://doi.org/10.1182/blood-2024-209163
Published: 2024
Journal Articles

Chemotherapy-Free Induction with Venetoclax and Azacitidine, Followed By Tandem CD19/CD22 CAR-T Cell Therapy As First-Line Treatment in Newly Diagnosed High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Prospective, Single-Center, Single-Arm, Phase 2 Trial

Mengyun Li, Qingya Cui, Xuekai Li, Wei Cui, Xiaoqian Chen, Yan Yu, Juan Chen, Xin Zhang, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4197.
https://doi.org/10.1182/blood-2024-207017
Published: 2024
Journal Articles

How to Improve the Efficacy of Venetoclax and Azacitidine（VA）for Newly Diagnosed Acute Myeloid Leukemia？a Prospective, Single-Center, Single-Arm, Phase 2 Trial for New Diagnosed AML

Xuekai Li, Mengyun Li, Wei Cui, Xiaoqian Chen, Yan Yu, Juan Chen, Xin Zhang, Qingya Cui, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4284.
https://doi.org/10.1182/blood-2024-208981
Published: 2024
Journal Articles

Targeting of the CD161 Inhibitory Receptor Enhances Bone Marrow-Resident Memory CD8 + T Cell-Mediated Immunity Against Multiple Myeloma

Liwen Wang, Linzhi Xie, Yi Zhou, Yan Yu, Shiming Tan, Qian Cheng, Rong He, Xin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3291.
https://doi.org/10.1182/blood-2024-198964
Published: 2024
Journal Articles

Integrative Genomic and Transcriptomic Profiling Reveals Distinct Molecular Subsets in Adult Mixed Phenotype Acute Leukemia

Qian Wang, Haiping Dai, Wenzhi CAI, Qinrong Wang, Zhu Mingqing, Lingzhi Yan, Yan Yu, Hongjie Shen, Yang Xu, Ying Wang, Miao Miao, Shengli Xue, Yue Han, Xiaowen Tang, Huiying Qiu, Aining Sun, Jinyan Huang, Depei Wu, Suning Chen
Journal: Blood
Blood (2022) 140 (Supplement 1): 9198–9200.
https://doi.org/10.1182/blood-2022-156862
Published: 2022
Journal Articles

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Yang Liang, PhD, Yun Wang, Yan-Yu Cai, Siliang Chen, Run-Cong Nie, Zhe-Yuan Qin, PhD, Fang Hu, Weida Wang, MD, Yu-Jun Dai, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 708.
https://doi.org/10.1182/blood-2019-126733
Published: 2019
Journal Articles

A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy

Liu Meijing, Rui Cui, MD, Juan Mu, Ji-jun Yuan, Nan Mou, Zhen-xing Yang, Jiang Yan-yu, Meng Juanxia, QI Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5124.
https://doi.org/10.1182/blood-2019-126398
Published: 2019
Journal Articles

CXCL9 Contributes To Chemotherapy-Induced Acute Intestinal Damage Through Proliferative Inhibition Of Epithelial Cells

Huili Lu, PhD, Hongyu Liu, Jiaqing Shen, Shunyan Weng, Lan Qian, Mingyuan Wu, Shunying Zhu, Yan Yu, Wei Han, Jianwei Zhu, Anja Moldenhauer, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5563.
https://doi.org/10.1182/blood.V122.21.5563.5563
Published: 2013
Journal Articles

Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity

Huili Lu, Shunying Zhu, Lan Qian, Di Xiang, Wu Zhang, Aifang Nie, Jin Gao, Mingyuan Wu, Jinming Gao, Bao Lu, Yan Yu, Wei Han, Anja Moldenhauer
Journal: Blood
Blood (2012) 119 (21): 4868–4877.
https://doi.org/10.1182/blood-2011-07-367581
Published: 2012
Includes: Supplemental data